More articles from Epigenetics

Fumarate Promotes EMT by Downregulating Antimetastatic miRNAs
Cancer Discovery Oct 2016, 6 (10) 1081; DOI: 10.1158/2159-8290.CD-RW2016-169
DNMT3A and TET2 Cooperate and Compete to Maintain HSC DNA Methylation
Cancer Discovery Sep 2016, 6 (9) 944; DOI: 10.1158/2159-8290.CD-RW2016-143
ZMYND8 Cooperates with JARID1D to Suppress Metastatic Gene Expression
Cancer Discovery Sep 2016, 6 (9) OF7; DOI: 10.1158/2159-8290.CD-RW2016-145
Mutations in Histone H3K36 Prevent Methylation and Drive Sarcomagenesis
Cancer Discovery Jul 2016, 6 (7) 689; DOI: 10.1158/2159-8290.CD-RW2016-092
Disrupting Insulated Chromosome Neighborhoods Can Activate Oncogenes
Cancer Discovery Apr 2016, 6 (4) 343; DOI: 10.1158/2159-8290.CD-RW2016-045
Atypical Teratoid/Rhabdoid Tumors Encompass Three Epigenetic Subtypes
Cancer Discovery Apr 2016, 6 (4) 342; DOI: 10.1158/2159-8290.CD-RW2016-044
AML Fusions Require Epigenetic Modifiers to Transform Cells
Cancer Discovery Mar 2016, 6 (3) OF4; DOI: 10.1158/2159-8290.CD-RW2016-011
Focal Amplification of Super-Enhancers Upregulates Oncogenic Drivers
Cancer Discovery Feb 2016, 6 (2) 118; DOI: 10.1158/2159-8290.CD-RW2015-239
Noncatalytic EZH2 Activity Is Required in SWI/SNF-Mutant Cancers
Cancer Discovery Jan 2016, 6 (1) 13; DOI: 10.1158/2159-8290.CD-RW2015-224
MLL5 Promotes Self-Renewing Glioblastoma Growth via H3.3 Suppression
Cancer Discovery Jan 2016, 6 (1) 9; DOI: 10.1158/2159-8290.CD-RW2015-231

Main menu